Matuhasi-Ogata phenomenon involving anti-ampicillin.
A 47-year-old group A, Rh1Rh1 woman treated with intravenous ampicillin for chronic pyelonephritis received two units of blood and also received oral cephalexin. Three months after the transfusions she was noted to have allo-anti-E and anti-c, and a 2+ positive direct antiglobulin test. Anti-E and anti-c could be eluted from her cells, yet neither antigen could be demonstrated on the patient's circulating red blood cells. Also present in the serum and in the eluate was anti-ampicillin antibody. Studies of the patient's red blood cell eluates using ampicillin-treated R1R1 and untreated R2R2 cells demonstrated anti-E complexed with anti-ampicillin in a drug-related example of the Matuhasi-Ogata phenomenon. Artificially created mixtures of anti-E and drug antibody could reproduce the effect in vitro. No effect of cephalexin could be demonstrated. The variability of the Matuhasi-Ogata phenomenon is discussed with regard to the sequence of antibody attachment, and the possible relationship to cephalexin is discussed. Drug antibodies may be involved in the Matuhasi-Ogata phenomenon in cases where another red blood cell antibody cannot be shown to be present.
D000667:Ampicillin / Q000276:immunology*; D000918:Antibody Specificity; D000937:Antigen-Antibody Reactions; D003165:Complement System Proteins; D005260:Female; D006801:Humans; D007164:Immunosorbents; D007564:Japan; D008875:Middle Aged; D012204:Rh-Hr Blood-Group System
D007164:Immunosorbents; D012204:Rh-Hr Blood-Group System; D000667:Ampicillin; D003165:Complement System Proteins